Pyridam Farma Tbk - Asset Resilience Ratio
Pyridam Farma Tbk (PYFA) has an Asset Resilience Ratio of 0.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Pyridam Farma Tbk for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2024)
This chart shows how Pyridam Farma Tbk's Asset Resilience Ratio has changed over time. See operational self-sufficiency of Pyridam Farma Tbk to measure how many days the company can operate on defensive assets alone.
Liquid Assets Composition Over Time
This chart breaks down Pyridam Farma Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PYFA current and non-current assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp1.24 Billion | 0.02% |
| Total Liquid Assets | Rp1.24 Billion | 0.02% |
Asset Resilience Insights
- Limited Liquidity: Pyridam Farma Tbk maintains only 0.02% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Pyridam Farma Tbk Industry Peers by Asset Resilience Ratio
Compare Pyridam Farma Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Krka d. d
WAR:KRK |
Drug Manufacturers - Specialty & Generic | 11.18% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623 |
Drug Manufacturers - Specialty & Generic | 4.97% |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755 |
Drug Manufacturers - Specialty & Generic | 24.59% |
|
Guangdong Taienkang Pharmaceutical Co. Ltd
SHE:301263 |
Drug Manufacturers - Specialty & Generic | 6.08% |
|
Tianjin Ringpu Bio Tech
SHE:300119 |
Drug Manufacturers - Specialty & Generic | 14.27% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
Annual Asset Resilience Ratio for Pyridam Farma Tbk (2001–2024)
The table below shows the annual Asset Resilience Ratio data for Pyridam Farma Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.03% | Rp1.64 Billion ≈ $96.20K |
Rp5.81 Trillion ≈ $340.51 Million |
-- |
| 2023-12-31 | 0.00% | Rp0.00 ≈ $0.00 |
Rp1.52 Trillion ≈ $89.14 Million |
-- |
| 2018-12-31 | 1.04% | Rp1.95 Billion ≈ $114.46K |
Rp187.06 Billion ≈ $10.96 Million |
+0.81pp |
| 2017-12-31 | 0.24% | Rp379.65 Million ≈ $22.25K |
Rp159.56 Billion ≈ $9.35 Million |
-0.58pp |
| 2016-12-31 | 0.82% | Rp1.37 Billion ≈ $79.99K |
Rp167.06 Billion ≈ $9.79 Million |
+0.74pp |
| 2003-12-31 | 0.07% | Rp51.00 Million ≈ $2.99K |
Rp68.27 Billion ≈ $4.00 Million |
-5.47pp |
| 2001-12-31 | 5.54% | Rp4.25 Billion ≈ $249.03K |
Rp76.67 Billion ≈ $4.49 Million |
-- |
About Pyridam Farma Tbk
PT Pyridam Farma Tbk engages in the development, production, and trading of pharmaceuticals primarily in Indonesia. The company operates through Pharmaceutical Products, Esthetic, and Toll Manufacturing Services; and Medical Equipments segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extra… Read more